Paper513952
Effects of vanadium on glucose metabolism in vitro.
Tolman EL and 4 others. Life Sci, 1979. Cited by 204 papers, by iCite.
Cite this record
ConductScience Library. Effects of vanadium on glucose metabolism in vitro. Papers, record 513952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/513952
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucose | Major topic |
| Vanadium | Major topic |
| Adipose Tissue | |
| Animals | |
| Glycogen | |
| In Vitro Techniques | |
| Liver | |
| Male | |
| Membranes | |
| Oxidation-Reduction | |
| Rats |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37958659 | Vanadium Compounds with Antidiabetic Potential. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958659 | PubMed |
| 36982458 | Biological Consequences of Vanadium Effects on Formation of Reactive Oxygen Species and Lipid Peroxidation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982458 | PubMed |
| 35481063 | A review on α-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes. | RSC Adv | 2022 | https://conductscience.org/library/papers/35481063 | PubMed |
| 35453475 | Overview of Research on Vanadium-Quercetin Complexes with a Historical Outline. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35453475 | PubMed |
| 32305626 | Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends. | J Trace Elem Med Biol | 2020 | https://conductscience.org/library/papers/32305626 | PubMed |
| 32226092 | Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications. | Coord Chem Rev | 2018 | https://conductscience.org/library/papers/32226092 | PubMed |
| 29524196 | Vanadium in Biosphere and Its Role in Biological Processes. | Biol Trace Elem Res | 2018 | https://conductscience.org/library/papers/29524196 | PubMed |
| 27890939 | The metal face of protein tyrosine phosphatase 1B. | Coord Chem Rev | 2016 | https://conductscience.org/library/papers/27890939 | PubMed |
| 26396569 | Cotherapy of Tiron and selenium against vanadium induced toxic effects in lactating rats. | Iran J Reprod Med | 2011 | https://conductscience.org/library/papers/26396569 | PubMed |
| 25237207 | The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells. | Coord Chem Rev | 2014 | https://conductscience.org/library/papers/25237207 | PubMed |
| 24741400 | Beneficial effects of natural Jeju groundwaters on lipid metabolism in high-fat diet-induced hyperlipidemic rats. | Nutr Res Pract | 2014 | https://conductscience.org/library/papers/24741400 | PubMed |
| 21799679 | Vanadium-Enriched Cordyceps sinensis, a Contemporary Treatment Approach to Both Diabetes and Depression in Rats. | Evid Based Complement Alternat Med | 2011 | https://conductscience.org/library/papers/21799679 | PubMed |
| 20339887 | A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds. | J Biol Inorg Chem | 2010 | https://conductscience.org/library/papers/20339887 | PubMed |
| 19948751 | A Contemporary Treatment Approach to Both Diabetes and Depression by Cordyceps sinensis, Rich in Vanadium. | Evid Based Complement Alternat Med | 2010 | https://conductscience.org/library/papers/19948751 | PubMed |
| 19641705 | Attenuation of ischemia-reperfusion induced changes in cardiac performance and sarcoplasmic reticulum function by vanadate. | Exp Clin Cardiol | 2003 | https://conductscience.org/library/papers/19641705 | PubMed |
| 15806386 | Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity. | J Biol Inorg Chem | 2005 | https://conductscience.org/library/papers/15806386 | PubMed |
| 14551811 | Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids. | J Biol Inorg Chem | 2003 | https://conductscience.org/library/papers/14551811 | PubMed |
| 12488596 | Different Forms of Vanadate on Sugar Transport in Insulin Target and Nontarget Cells. | J Biomed Biotechnol | 2002 | https://conductscience.org/library/papers/12488596 | PubMed |
| 12190123 | Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum). | Mol Cell Biochem | 2002 | https://conductscience.org/library/papers/12190123 | PubMed |
| 10839208 | Anti-diabetic and toxic effects of vanadium compounds. | Mol Cell Biochem | 2000 | https://conductscience.org/library/papers/10839208 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/513952
GET https://conductscience.org/api/papers/v1/513952/cited_by?page=2